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Abstract
Intestinal cytochrome P450 subclass 1A1 (CYP1A1) contributes to a metabolic ‘‘shield’’ protecting the host from ingested
carcinogens such as polycyclic aromatic hydrocarbons (PAH). The expression of CYP1 (including CYP1A2 and CYP1B1) is
considered to depend solely on a heterodimeric transcription factor consisting of the arylhydrocarbon receptor (AHR) and
the AHR nuclear translocator (ARNT). So far, no interference has been noted between the regulation of CYP1 and the
activation of Toll-like receptor 2 (TLR2), which modulates the inflammatory response to bacterial cell wall components in
immune cells and enterocytes. Here we report that intestinal CYP1A1 is silenced in TLR2-deficient mice, even when under
exposure to the carcinogenic PAH benzo[a]pyrene (BaP). In contrast, hepatic CYP1A1 was moderately induced in TLR2-
deficient mice without restoring their ability to clear BaP from systemic circulation, as present in wild-type animals. After
feeding of BaP for 21 days, only TLR22/2 mice, but not their wild type littermates developed polyps in the colon. Gene
expressions and protein concentrations of AHR and ARNT in the intestine did not differ between the genotypes. In
conclusion, the presence of ligands for TLR2 of bacterial origin seems to be crucial for detoxication of luminal carcinogens
by CYP1A1 in the intestine. This unprecedented finding indicates a complex interplay between the immune system of the
host and intestinal bacteria with detoxication mechanisms. This highlights the relevance of intestinal microbiota when
trying to unravel pathways present in mammals and opens new perspectives for research in human health.
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Introduction
The toll-like receptor (TLR) family comprises a group of type 1
transmembrane glycoproteins, which recognize microbe-associat-
ed molecular patterns (MAMPs) [1]. Binding of MAMPs to these
receptors induces innate immune responses such as cytokine
production, phagocytosis initiation, antigen presentation and other
molecular events resulting in inflammation and its autoregulation
[2]. Toll-like receptor 2 (TLR2) in association with TLR1 or
TLR6 is crucial for recognition of bacterial lipoproteins, lipopep-
tides, and other microbial cell wall components [3] and
consequent induction of pro-inflammatory responses predomi-
nantly in polymorphonuclear leukocytes and phagocytes [4].
TLR2, together with TLR1 or TLR6, signals as part of a
heterodimer in association with lymphocyte antigen 96 (MD2) by
recruitment of myeloid differentiation primary response protein 88
(MyD88), toll-interleukin 1 receptor (TIR) domain containing
adaptor protein (TIRAP), and toll-like receptor adaptor molecule
2 (TICAM2), to their intracellular signaling domains [5]. The
TLR2-containing agglomerate binds the intracellular adaptor
complex (IRAK1) to trigger the intracellular activation of MAPKs
and of the canonical pathways linked to NF-kappaB and
phosphoinositide 3-kinase (PI3K)/AKT. The coordinated signal-
ing directs production of immunoregulatory mediators (e.g., IL-1
beta, TNF-alpha) [6]. Some bacteria, which are considered to
have probiotic properties and harbour ligands for TLR2, have
been discussed as protective agents in colon cancer development
[7].
Polycyclic aromatic hydrocarbons (PAH) such as benzo[a]py-
rene (BaP) and phenanthrene are cancer-inducing agents found in
tobacco smoke, automobile emission exhaust, industrial waste, and
even certain foodstuffs [8]. Data from epidemiological studies,
biochemical and molecular investigations support the idea of PAH
such as BaP to be primary causative carcinogens in the lung [9]
and the bladder [10]. The key reactive intermediate benzo(a)py-
rene-7,8-diol-9,10-epoxide (BPDE) can link covalently to DNA,
therefore causing genetic aberrations [10]. BPDE is formed
endogenously in a multi-step procedure in which cytochrome
P450 (CYP) subclasses CYP1A1 and CYP1B1 are of special
relevance in both metabolic activation (epoxidation) and detoxi-
cation [9]. The regulation of CYP1 is considered so far to be
unrelated to TLR2 activation [11]. The expression of CYP1 is
under control of the cytosolic arylhydrocarbon receptor (AHR)
[12], which heterodimerizes upon ligand (e.g., PAH, dioxin)
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binding with the aryl hydrocarbon receptor nuclear translocator
(ARNT). This heterodimer forms a high-affinity DNA binding
complex that binds to specific target DNA sequences known as
aryl hydrocarbon receptor-response elements (AHRE) in the
regulatory areas of the responsive CYP1 genes [13].
In an initial experiment, we identified the basal expression of
CYP1A1 to be dramatically reduced in the intestine of TLR22/2
mice compared to wild-type (WT) animals with the corresponding
genetic background. In a subsequent feeding study, we proved that
feeding with BaP does neither induce intestinal CYP1A1 mRNA
nor protein expression in TLR22/2 mice in contrast to WT mice
and that TLR22/2 animals are incapable of systemic BaP
clearance.
Materials and Methods
Animals
C57BL/6 WT mice and B6.129-TLR2tm1Kir/J mice were
obtained from the Jackson Laboratory, Bar Harbor, Maine, USA.
B6.129-TLR2tm1Kir/J mice are homozygous for the TLR2tm1Kir
mutation and do not produce functional TLR2 protein [14]. Mice
were 13–14 weeks at the start of the experiment. Animals were
kept under 12 h-light-dark cycles at 22uC.
Mice were handled by experienced animal keepers and all
protocols and procedures applied were approved by the
representative of the Danish National Committee on Animal
Experimentation (Forsøgsdyrtilsynet). Special care was taken to
minimize any suffering of the mice.
Feeding experiment
Mice had ad libitum access to water and chow (Altromin 1324
pellets, Brogaarden, Gentofte, Denmark) that was soaked for
24 hours with corn oil (1 mL corn oil/12 g chow), which either
contained benzo[a]pyrene (BaP, Sigma-Aldrich, Brøndby, Den-
mark) (5.8 mg/g corn oil) or not. In the treatment groups, the
daily intake was adjusted to be 100 mg BaP/kg/day [15], based
on the average daily chow consumption of mice. Mice of each
genotype (wild-type and TLR2tm1Kir/J, 30 in total) were divided
into two groups (7–8 animals/group), one of them receiving BaP.
Mice were euthanized at 21 days after pentobarbital sedation by
exsanguination.
Collection of plasma and tissues
Blood samples were collected in EDTA-treated syringes
(Kruuse, Langeskov, Denmark) and centrifuged (30006g,
10 min, 4uC). The supernatant plasma was kept at 280uC before
HPLC analysis. Immediately after exsanguination, the small
intestines were removed, rinsed with an ice-cold aqueous solution
of 1.15% KCl, 1 mM phenylmethanesulfonylfluoride, and
0.5 mM DTT. The epithelial cell layer was scraped off with the
edge of a cover glass used for microscopical purposes and RNA
was isolated according to the TRIzol Plus RNA isolation protocol
(Invitrogen, Taastrup, Denmark). The aqueous phase was
transferred to RNA purification spin columns (RNeasy Mini Kit,
Qiagen, Hilden, Germany) and was isolated according to the
RNeasy protocol.
The liver was first perfused with TRI Reagent (Ambion,
Applied Biosystems, Foster City, CA, USA), followed by perfusion
next with RNAlater (Applied Biosystems, Nærum, DK), cut into
small pieces, and shock-frozen with liquid nitrogen. The isolated
RNA (ABI Prism 6100 Nucleic Acid Prep Station using Nucleic
Acid Purification Lysis Solution and Total RNA Purification
Trays, Applied Biosystems) was further purified with Total RNA
Isolation kit (Agilent).
Concentrations of RNA were measured with NanoDrop ND-
1000 spectrophotometer (Thermo Fisher Scientific Inc., Roskilde,
DK) or the Quant-iT RNA Assay Kit (Invitrogen) and purity was
certified with the BioAnalyzer 2100 (Agilent).
For protein extraction, untreated mucosal and hepatic tissue
was shock-frozen with liquid nitrogen. All samples were kept
frozen at 280uC until use. Large intestines for histological
investigation were flushed free of fecal contents with ice-cold
phosphate buffered saline (PBS), cut open along the longitudinal
median axis, and fixed between filter paper in 10% formalin.
Microarray measurements
Two hundred nanograms of total RNA from six mice/group
(WT and TLR22/2) were separately converted into labeled cRNA
with nucleotides coupled to a Cyanine 3-CTP (Cy3) fluorescent
dye using the One-Color Microarray-Based Gene Expression
Analysis, Low Input Quick Amp Labeling (version 6.0 protocol)
(Agilent Technologies). Cy3-labeled cRNA (1.65 mg) from each
mouse was hybridized to Agilent Whole Mouse Genome Oligo
Microarrays (six per group) (G4122F) for 17 h at 65uC. The
hybridized microarrays were scanned using an Agilent DNA
Microarray Scanner with Surescan High-Resolution Technology
(G2505C) and evaluated (Agilent Technologies Feature Extraction
software version 10.5.1.1).
qRT-PCR
For cDNA synthesis, total RNA was reverse-transcribed into
cDNA using the High-Capacity cDNA Reverse Transcriptase Kit
(Applied Biosystems). The reverse-transcription conditions were as
follows: 25uC for 10 min, 37uC for 120 min and 85uC for 5 sec in
a VWR Unocycler (VWR, West Sussex, UK).
Gene expression assays for qRT-PCR were purchased from
Applied Biosystems. Assay IDs were as follows: Cyp1A1 (Mm00487
218_m1), Cyp1A2 (Mm00487224_m1), Cyp1B1 (Mm00487229_m1),
Ahr (Mm01291777_m1), and Arnt (Mm00507836_m1). TaqMan
Gene Expression Master Mix, (Applied Biosystems) was mixed with
4 mL of diluted first-strand cDNA as template and TaqMan Gene
Expression Assay mix (forward primer, reverse primer and FAMTM
dye-labeled TaqMan MGB probe) to give a final volume of 10 mL
(2.5 mg/mL cDNA) per reaction. The 7900HT Fast Real-Time PCR
System (Applied Biosystems) was used for duplicate analyses. Cycle
conditions were 2 min at 50uC and 10 min at 95uC, followed by 40
cycles of 15 s at 95uC and 1 min. at 60uC. Assays specific for b-actin
(Mm01205647_g1) and Gtf3c2 (Mm00510828_m1) were used as the
reference genes to account for variability in the concentration of
cDNA (Genevestigator software) [16]. The threshold cycle (DDCt)
method of comparing expression data was applied. Gene expression
was normalized to Ct values of b-actin/Gtf3c2 [DCt=Ct(target)-
Ct(reference)] and comparative gene expression was calculated as
DDCt=DCt(treatment)-DCt(control). The fold change values were
calculated as 22DDCt.
Immunoblot analysis
Microsomes from liver and small intestines were prepared from
samples homogenized in 3 mL of 1.15% KCl, 1 mM PMSF, and
0.5 mM DTT to 200 mg of mucosal tissue and 500 mg of hepatic
tissue by differential ultracentrifugation (70 Ti rotor in a
Beckmann Coulter L8-70M centrifuge): 20 min at 16,0006g
(4uC) pre-centrifugation and 100,0006g for 60 min. The resulting
pellet was suspended in 1 mL of 10 mM Tris-HCl buffer with
1 mM EDTA and 1.15% KCl, pH 8.0, aliquoted, and stored at
280uC until use. Protein concentrations were determined at
280 nm using NanoDrop ND-1000 spectrophotometer. Equal
amounts of microsomal proteins were separated on Bis-Tris
Regulation of CYP1 by TLR2
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polyacrylamide gels (NuPAGE 4–12% Bis-Tris, Invitrogen) under
denaturating conditions and transferred on PVDF membranes
(Immobilon–P, Millipore, Bedford, MA, USA) in NuPAGE
transfer buffer (Invitrogen). Membranes were then blocked with
0.5% bovine serum albumin dissolved in TBS (20 mM Tris-HCl,
pH 7.3, 150 mM NaCl) containing 0.1% Tween-20 and 0.02%
NaN3). The membrane was incubated with polyclonal rabbit anti-
mouse CYP1A1/2 (ARP41405, Nordic Biosite, Ta¨by, Sweden)
and polyclonal rabbit anti-mouse antibodies. PTGS2 (PAB6665,
Abcam, Cambridge, UK) diluted in TBS-T was included as
reference protein [17]. After triplicate washes in TBS-T, the
membrane was incubated with a horseradish peroxidase-conju-
gated secondary antibody (goat-anti-rabbit, Abcam). Relative
protein concentrations of AHR and ARNT were measured after
lysis of mucosal cells (T-PER Tissue Protein Extraction Reagent
with Halt Protease Inhibitor Cocktail, Thermo Scientific, Herlev,
Denmark) from mice of both genotypes. Primary antibodies used
were AHR polyclonal antibody (goat-anti-mouse AHR,
PAB12101), ARNT monoclonal antibody, clone H1beta234
(MAB2370) (both: Abnova), and polyclonal rabbit-anti-mouse a-
actin antibody (A2668, Sigma-Aldrich). Secondary antibodies
were polyclonal (anti-mouse IgG, anti-goat IgG, and anti-rabbit
IgG, all peroxidase-conjugated, DAKO, Glostrup, Denmark).
Protein bands were visualized using enhanced chemiluminescence
reagent (ECL, Amersham, Buckinghamshire, UK). Relative
chemoluminescence intensities of CYP1A1, CYP1A2, AHR, and
ARNT protein were normalized.
Histology
The colon of mice under investigation was examined for
presence of aberrant crypt foci and other morphological
abnormalities. After 24 hours in fixative, colons were stained with
0.2% methylene blue (VWR, Leuven, Belgium) in 10% formalin
solution for 30 min and washed with PBS/methanol 80/20 v/v.
The tissue was examined with an Olympus BX51 light microscope
equipped with an Olympus DP20 digital color camera (40-fold
magnification).
HPLC analysis of benzo[a]pyrene (BaP)
BaP was extracted by a previously established extraction
method for lipophilic compounds from blood plasma [18]. In
brief, 200 mL of ethanol (p.a., Merck, Darmstadt, Germany) were
added to 400 mL of plasma. After homogenization, 500 mL of
toluene (p.a., Merck) containing chrysene (Sigma-Aldrich, 25 mg/
mL) as internal standard were added. After homogenization and
phase separation, the toluene phase was transferred into fresh
tubes. The solvent was evaporated and the residue was dissolved in
100 mL of acetonitrile (ACN), 20 mL of which were directly
applied to the HPLC system (WatersTM 717plus autosampler,
WatersTM HPLC pump 510, Waters degasser, and a Varian 9070
Fluorescence detector with a Luna 5 mm C18(2) column,
Phenomenex, Allerød, Denmark); flow was 1.0 mL/min, excita-
tion/emission wavelengths 264/434 nm, resp. The specifity of the
BaP analysis procedure was ascertained with a BaP reference
standard (TraceCERTH, Sigma-Aldrich). The chromatograms
were evaluated using the Millenium 2010 v.3.05 software package.
The BaP concentrations were calculated taking the recovery of
chrysene into account.
Statistical analysis
Microarray data obtained from image analysis were processed
with the Limma package [19] including background correction
and quantiles normalization. A linear model was fitted and
modified t-statistics (empirical Bayes shrinkage) was applied using
the default proportion and limits for standard deviation (0.01 and
[0.1, 4] respectively). The fold-changes reported are ratios of the
averages calculated for the wild-type and TLR22/2 animals. P
values were calculated for the group of genes the averaged
expression of which differed by a factor of at least 4.
Significances of differences for inter-group comparisons of PCR,
immunoblot data, and circulating BaP concentrations were
calculated by two-way ANOVA and Tukey’s post-hoc test
(Statistica v.9.0 package, StatSoft, Tulsa, OK, USA), partly with
logarithmically transformed data.
Results
In the first experiment, differences in gene expression in the
intestines between mice that were deficient for functional TLR2
protein and wild type (WT) animals were measured with Agilent
Whole Mouse Genome Oligo Microarrays. As evident from the
results of the microarray analysis (Table 1), 14 genes were up- or
down-regulated at least 4-fold in the intestines of the TLR2-
deficient animals compared to those in WT mice. Out of all
measured gene expressions, that of the Cyp1a1 gene was changed
the most – its expression was negligible in the intestines of mice
that did not express functional TLR2 (22-fold reduction compared
to WT animals). Of note, the expression of mRNA for
phospholipase A2 [IVC cytosolic, calcium-independent - Pla2g4c,
as assayed by probes targeting the sequences NM_001004762
(RefSeq) and AK145339 (Genbank)], was significantly increased in
the intestine as a result of the loss of functional TLR2.
In the consequent intervention study, we investigated whether
feeding with BaP induces expression of intestinal mRNAs for
CYP1A1, CYP1A2, and CYP1B1 as well as concentrations of CYP
1A1/CYP1A2 protein in TLR22/2 mice and in wild-type animals.
After the end of the feeding period (21 days), regulation of mRNA
production for CYP1 was measured by qRT-PCR. In the intestines
of WT animals, BaP feeding induced the expression of CYP1A1
mRNA to be approx. 90-fold and that of CYP1A2 mRNA to be
approx. 24-fold (Figure 1A). In contrast, neither CYP1A1 mRNA
nor CYP1A2 mRNA expressions were significantly changed in the
intestines of the TLR22/2 animals. The expression of CYP1B1
mRNA did not change significantly in the intestines of BaP-fed WT
mice (Fig. 1A). In contrast to the intestine, BaP feeding enhanced
the hepatic expression of CYP1A1 mRNA and CYP1A2 mRNA
approx. 3.5-fold and 1.5-fold, respectively, in TLR22/2 animals,
but not in that of the WT mice (Fig. 1A). The expression of mRNA
for the arylhydrocarbon receptor (AHR) and its heterodimeric
partner, arylhydrocarbon receptor nuclear translocator (ARNT)
differed neither in the intestine nor in the liver of WT or TLR22/2
animals under any feeding regimen (Table 2).
Quantitative RT-PCR confirmed the finding of the microarray
analysis that basal mRNA expression of CYP1A in the intestine
was significantly lower in TLR22/2 mice (,1% of control).
Without reaching significance, the average protein concentration
of CYP1A1 was moderately higher in TLR22/2 animals
compared to WT mice that were not exposed to BaP (Fig. 1B/
C). In parallel to the mRNA expression, BaP feeding resulted in
significantly enhanced expression of CYP1A1 protein in the
intestine of WT mice, but not in that of the TLR22/2 animals
(Fig. 1B/C). In the liver of the TLR22/2 animals, BaP
supplementation enhanced CYP1A1 protein production only in
TLR22/2deficient mice (,100-fold), but not in that of WT
animals (Fig. 1B/C). All groups showed a markedly higher
concentration of CYP1A2 in the liver compared to the intestine.
The expression of this protein was not significantly affected by BaP
feeding either in WT or in TLR22/2 animals.
Regulation of CYP1 by TLR2
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Protein expressions of AHR and ARNT did not differ
significantly between TLR22/2 and WT mice and molecular
masses of both proteins were identical in both genotypes (Figure 2).
After overnight deprivation of the BaP-loaded chow, the blood
plasma of all WT animals was virtually free of BaP (concentration
below detection limit, ,0.05 ng/mL), while the TLR22/2 mice
were incapable of clearance of the absorbed BaP (conc.= 61.7
610.5 ng/mL, n=7, P,0.001; Fig. 3).
Only the surface of colon mucosa of TLR22/2 animals that
were fed with BaP displayed polyp-like structures, but not the
colons of the animals from the other three groups (Fig. 4). No
preneoplastic foci were seen in any of the colonic tissues.
Discussion
In face of the carcinogenic potential of PAH, of which BaP is
the best investigated one [9], considerable efforts were undertaken
to understand the mechanisms by which PAH causes cancer
development in different organs. Since the ground-breaking study
by Wattenberg and colleagues [20], numerous studies have been
carried out to clarify the role of hemethiolate monooxygenases
(CYPs) in detoxification of PAH in the intestine. These studies
have been related to identification and allocation of different
PAH-metabolizing CYPs [21], to transcriptional and translational
control of their expression [22,23] and to regulation of their
activity by xenobiotics from industrial processes [8] or dietary
intake [24–26]. Today, it is clear that CYP1A1 is the key enzyme
in metabolizing PAH (together with CYP1B1 and some CYP3A
enzymes) [15,27,28], while CYP1A2 predominantly converts polar
carcinogenic amines [29]. The intestinal expression of murine
CYP1A1 is considered to be minimal under non-stimulated
conditions and might depend on flavonoid content in the chow
[21]. As observed previously [16], CYP1A2 expression was
constitutively higher in the liver compared to that in the intestine,
but remained unchanged after BaP feeding, though a compensa-
tory CYP1A2 induction in cyp1a12/2 mice was reported
previously [17]. Already under non-stimulated conditions, a
significant suppression of CYP1A1 mRNA expression was
measured in TLR22/2 mice in the current study (Table 1). In
contrast to that, this difference was not noted at the protein level,
which might be explained by an increased protein stability
phenomenon. The results from the intervention part of the study,
in which both types of genotypes (TLR22/2 and WT) were fed
BaP, which is a strong inducer of CYP1, confirmed our working
hypothesis that the AHR-ARNT system regulating intestinal
CYP1A expression [12] depends virtually on intact TLR2
signaling.
In line with previous findings [21], the initially low expression of
both mRNA and protein of CYP1A1 in the murine intestine can
considerably be increased by BaP feeding in animals with a
functional TLR2 receptor. This induction of hydroxylase activity
results in induction of both metabolic activation and detoxication
of PAH. Metabolic activation, generating reactive intermediates
(epoxides) capable of binding to DNA, was considered for decades
to be the key pro-carcinogenic process [30]. This concept seemed
substantiated by studies on mice with high levels of active CYP1A1
(due to a high affinity AHR), which were more susceptible to
cancers and genotoxicity when the PAH was brought in direct
contact with the corresponding organs, but not after oral, systemic
application [31,32]. However, BaP feeding (125 mg/kg/day)
results in much higher acute toxicity, lethality, and formation of
BaP-DNA adducts in the gastrointestinal tract, liver, and other
organs of CYP1A12/2 mice [17]. Hence, in the intact animal,
intestinal CYP1A1 activity seems important in elimination and
detoxification of PAH (and other toxic substrates of CYP1A1) and
is, in all likelihood, an important factor in cancer prevention,
especially when the activity of phase II enzymes is taken into
consideration [11,17]. The assumption that a high activity of
Table 1. Relative gene expressions in the intestine of TLR2-deficient that are changed at least 4-fold compared to wild-type mice.
Probe set Target ID Gene symbol Gene name FC
Raw
P value
Adjusted
P value
Up-regulated
A_52_P17207 AK145339 Pla2g4c phospholipase A2, group IVC (cytosolic, calcium-
independent)
9.6 1.2361022 3.0661021
A_51_P224263 NM_134052 Adi1 acireductone dioxygenase 1 9.3 2.95610210 1.2261025
A_51_P428360 NM_023881 Retnlb resistin like beta 9.2 1.9761022 3.4361021
A_52_P243075 NM_001004762 Pla2g4c phospholipase A2, group IVC (cytosolic, calcium-
independent)
7.7 1.6761022 3.3061021
A_52_P228437 AK088871 Mbnl1 muscleblind-like 1 (Drosophila) 5.1 5.2261027 1.1361023
A_52_P203440 U90926 U90926 cDNA sequence U90926 5.0 3.8561023 2.3061021
Down-regulated
A_51_P279693 NM_009992 Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 222.5 1.2361024 5.8461022
A_52_P731333 AK042046 214.1 2.1261028 1.2561024
A_52_P520788 AK039908 Scfd1 sec1 family domain containing 1 210.3 5.5061029 5.6861025
A_51_P215627 NM_207229 Plac9 placenta specific 9 28.8 5.3961029 5.6861025
A_51_P162984 NM_013637 Prm1 protamine 1 27.3 1.2661023 1.6261021
A_51_P423290 XM_284198 Mmrn1 multimerin 1 27.1 1.2461026 2.5661023
A_52_P565847 NM_001004153 AU018091 expressed sequence AU018091 24.9 3.8961022 4.0861021
A_51_P194099 NM_009381 Thrsp thyroid hormone responsive SPOT14 homolog (Rattus) 24.2 2.0861022 3.4661021
RNA was isolated from intestines of six wild-type and six TLR22/2 mice and gene expression was measured by applying cRNA from each mouse individually on an
Agilent Whole Mouse Genome Oligo Microarray (G4122F). CYP1A1 expression was nearly absent (296%) in animals deficient for the Tlr2 gene.
doi:10.1371/journal.pone.0032309.t001
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Figure 1. Expression ofmRNA and protein production of hepatic and intestinal CYP1A1, CYP1A2, and CYP1B1. (A) Gene expression levels
for cytochrome P450 isoforms 1A1, 1A2 and 1B1 in the intestine and liver of mice that were either deficient for TLR2 (TLR22/2) or not and that were either
fed with chow soaked with corn-oil with benzo[a]pyrene (BaP) or without (n=7–8 animals/group). Analyses were performed by qRT-PCR and statistical
analysis was performed by two-way ANOVA followed by Tukey’s post-hoc test. Values are given as means6 SEM; *(**/***): P,0.05 (0.01/0.001, resp.) vs.
WT group without BaP feeding; {({{/{{{): P,0.05 (0.01/0.001, resp.) vs. WT group with BaP feeding; { ({{/{{{): P,0.05 (0.01/0.001, resp.) vs. TLR22/2
group without BaP feeding; (B) Immunoblot analyses of protein expressions of CYP1A1 and CYP1A2 in the small intestine and the liver of mice that were
either deficient for TLR2 (TLR22/2) or not and were either fed with BaP for 3 weeks (100 mg/kg/day) or not. For all proteins investigated, lanes were
loaded with 50 mg of microsomal protein per lane. Prostaglandin-endoperoxide synthase 2 (PTGS2) was used as a loading standard. (C) Densitometric
evaluation of chemoluminescence of CYP1A bands: BaP feeding induced massively CYP1A1 protein production in the intestine of wild-type animals, but
not in that of TLR22/2 mice. In contrast, CYP1A1 was induced moderately in the liver of TLR22/2 animals, but not in that of wild-type mice.
doi:10.1371/journal.pone.0032309.g001
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CYPs in the gastrointestinal tract is protective in cancer
development is also substantiated by a study in which significantly
suppressed levels of three CYPs were found in non-malignant
intestinal tissue of patients with adenoma compared to healthy
controls [33].
Based on the findings of the current study, the protection of
inner organs from the effects of BaP feeding by intestinal
CYP1A1 [34] depends – by a so far unidentified mechanism – on
the functional activation of the TLR2 receptor and, therefore, on
the presence of an intestinal microflora providing ligands for
TLR2. This concept is substantiated by the current study as
CYP1A1 is induced in the liver of TLR22/2 mice, which lack
this intestinal ‘‘shield’’. Due to the absence of intestinal
detoxication in these animals, a higher concentration of BaP
might reach the liver and might there induce CYP1A1 expression
by the known AHR/ARNT pathway. However, this induction
seems not to be sufficient as the TLR22/2 mice – in contrast to
the WT mice - were incapable of clearing BaP from their
Table 2. Hepatic and intestinal mRNA expression of AHR and ARNT in TLR22/2 and wild-type mice with and without BaP feeding.
AHR ARNT
TLR2 + + 2 2 + + 2 2
BaP 2 + 2 + 2 + 2 +
Intestine 1.00 (0.43) 1.41 (0.42) 1.67 (1.01) 2.65 (3.17) 1.00 (0.32) 1.05 (0.19) 1.01 (0.43) 1.48 (0.34)
Liver 1.00 (0.16) 0.78 (0.15) 0.64 (0.17) 0.73 (0.18) 1.00 (0.10) 0.72 (0.10) 0.73 (0.08) 1.04 (0.15)
None of the values differs significantly from another (2-way ANOVA, group-wise comparisons for organs and genes). Values are averages (standard deviation) and are
standardized towards Gtfc2 and b-actin.
doi:10.1371/journal.pone.0032309.t002
Figure 2. (A) Representative Western blots and (B) standardized protein expression of the aryl hydrocarbon receptor (AHR) and the
aryl hydrocarbon receptor nuclear translocator (ARNT). The protein expression in the intestinal mucosa of TLR22/2 mice and in that of WT
mice (n = 5 animals/group) was normalized to a-actin. Statistical analysis was performed with Student’s t-test. The expression of both proteins did not
differ significantly between the genotypes (P=0.394 for AHR and 0.737 for ARNT); CL: chemoluminescence.
doi:10.1371/journal.pone.0032309.g002
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circulation 16 h after cessation of BaP feeding. Hence, the
hepatic induction of CYP1A1 by the permeating BaP seems not
to be able to compensate for the absence of intestinal CYP1A1
activity in TLR22/2 animals.
Previous studies indicate a protective role of TLR2 in the
development of intestinal cancers. TLR2 signaling is a protective
factor against colitis-induced cancer [35] and the absence of
bacteria from the intestinal lumen results in polyp formation, as
Figure 3. Representative HPLC chromatograms of the blood plasma extract of WT mice (A) and TLR22/2 mice (B). In contrast to WT
animals, mice that were deficient for TLR2 were incapable to eliminate BaP from their circulation after an over-night fast. The major peak in both
chromatograms was caused by the internal standard chrysene (retention time: 7.5 min). Chromatograms of the blood plasma from TLR22/2 animals
(n = 7 per group) showed a clear BaP peak (right chromatogram, retention time 11.5 min) after over-night (16 h) deprivation from BaP-charged chow,
while the blood plasma of the WT animals was virtually free of BaP (left chromatogram, concentration below 0.05 ng/mL).
doi:10.1371/journal.pone.0032309.g003
Figure 4. Morphology of colon mucosa from TLR22/2 and wild-type mice with and without BaP feeding. Histological view on
methylene-blue stained colon mucosa of mice that were either deficient for functional TLR2 (or not and that were either fed with BaP for 21 days or
not. (A) wild-type mice fed corn-oil soaked chow (control diet) (B) wild-type mice fed with BaP (C) TLR22/2 mice on control diet (D) TLR22/2 mice on
BaP diet. In the two groups of mice that were fed with BaP, only the colon mucosa of TLR22/2 showed a dense surface coverage with polyps (D),
indicating hyperproliferation of the colon mucosa tissue. Bar = 1 mm.
doi:10.1371/journal.pone.0032309.g004
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seen in studies with gnotobiotic mice [36]. The formation of these
pre-carcinogenic proliferations, as also observed in the current
study, might be based on a lack of intestinal CYP1A1 activity due
to absent TLR2 ligands, which are in first line cell wall
components of both Gram-positive and Gram-negative commen-
sal bacteria harbored in the intestinal lumen [37]. The knowledge
on the effect of TLR2 mutations on the development of malignant
diseases in humans is limited so far. In a Japanese population,
subjects with the 2196 to 2174del/del genotype of TLR2 were
shown to be about six times as susceptible to gastric cancer
compared to those with the corresponding WT alleles [38].
The mechanism by which TLR2 affects the AHR-associated
regulation of CYP1A expression remains to be clarified. To the
best of our knowledge, none of the intracellular transcriptional
regulation factors linked to TLR2-activated signaling pathways [6]
has been related to regulation of CYP1A1, though it has become
clear that both production of interleukin 22 by cd T cells and their
expansion depend on AHR availability [39] and mice that lack
AHR are much more susceptible to infections with Toxoplasma
gondii [40], suggesting a relevant role for AHR/ARNT signaling in
immune response.
In the current study, the observed dependency of CYP1A1
expression on TLR2 functionality is very unlikely to be due to a
malfunction of the AHR/ARNT signaling pathway as an artifact
of TLR2 deletion for several reasons: (i) both the TLR22/2 mice
and the WT animals carry Ahr alleles that result in intestinal
mucosa proteins of identical molecular mass (Figure 2). Therefore,
the prevalence of different Ahr alleles, which might result in the
formation of proteins with different ligand affinities [41] can be
excluded. (ii) Both the mRNA expression levels of both genes and
the corresponding intestinal protein concentrations were un-
changed in TLR22/2 animals compared to WT mice (Table 2,
Figure 2) (iii) CYP1A2, which also depends on AHR/ARNT
regulation [10], is expressed at high levels in the liver and also
moderately in the intestine. This would not be the case if the AHR
functionality would be impaired; (iv) CYP1A1 is induced in the
liver of TLR22/2 mice after exposure to BaP, indicating a well-
functioning regulation by AHR/ARNT in this organ; (v) none of
the genes that were shown to be altered by genetic deletion of
AHR in mice [42] were found to be significantly changed in the
TLR22/2 mice (Table 1). This composite evidence strongly points
towards a principal availability of an intact AHR/ARNT signaling
pathway in the used TLR22/2 mice model.
Besides detoxication of polyaromatic xenobiotics, CYP1A1 is
capable of converting endogenous arachidonic acid (AA) into a
spectrum of different epoxyeicosatrienoic acids (EETs) and
hydroxyeicosatetraenoic acids (HETEs) (i.e. 19-HETE), in a
number of organs, including the intestine [43–45]. The production
of immunomodulating HETEs and EETs [46,47] by CYP1A1
might explain its link to TLR2 as a sensor for intestinal bacteria.
An active role of CYP1-generated AA metabolites in TLR2
deficiency is emphasized by the fact that phospholipase A2, the
activity of which results in promotion of AA liberation, is
significantly induced in TLR22/2 mice (Table 1). This induction
might be explained by a lack of a negative feed-back signal due to
the suspected incapability of the animals to form CYP1A1-
associated AA metabolites, as observed for other substrates of this
enzyme [12].
In conclusion, CYP1A1-facilitated carcinogen detoxication
might be under control of TLR2-dependent signaling. Whether
the activity of intestinal CYP1A can be influenced by TLR2
ligands and by which molecular mechanisms TLR2 regulates
CYP1A expression in the intestine needs to be clarified in future
studies. Experiments with gene knockout animals, which show the
involvement of other TLRs and intracellular molecules that are
related to TLR signaling, might contribute to the understanding of
the interaction between TLR2 and CYP1A1 in the intestine.
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